PACS Group, Inc. logo PACS - PACS Group, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $48.50 DETAILS
HIGH: $52.00
LOW: $42.00
MEDIAN: $50.00
CONSENSUS: $48.50
UPSIDE: 28.48%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 90% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 37.4% above fair value
Current Price $37.75
Bear Case $27.47 27.2% downside ($27.47 - $37.75) / $37.75 = -27.2% ROTCE 16.3% → 4.00x TBV
Fair Value $27.47 27.2% downside ($27.47 - $37.75) / $37.75 = -27.2% ROTCE 21.8% → 4.00x TBV
Bull Case $27.47 27.2% downside ($27.47 - $37.75) / $37.75 = -27.2% ROTCE 25.1% → 4.00x TBV

Adjust Assumptions

21.8%
6.0%

Key Value Driver

ROTCE (21.8%) vs. cost of equity (6.0%)

Implied Market Multiple 6.8x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $48.50 from 8 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $27.47 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $48.50 (from 8 analysts). Our estimate is 54% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly